NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Apr 17, 2029 (in 914 days)
Similar opportunities open now
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jul 2029Up to $500K
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses May 2029
- NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $500K
Classification and identifiers
- Solicitation number
- PAR-27-051
- Assistance listing (CFDA)
- 93.853
Amount
Amount not listed here. Check the official program.
Who can apply
Nonprofits can apply here. Check the eligibility details below to see if your organization fits.
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute on Drug Abuse seeks to advance its mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study to conduct research consistent with study objectives that will maximize the scientific utility of these limited samples. Research proposals should expand the knowledge gained from these studies and advance our understanding the multiple genetic and environmental factors, including exposure to substances, that affect health and disease over the course of a lifetime. Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 an...